Chihiro Yabe

Corporate Officer/Principal bij Kyoto Prefectural University of Medicine

Health Technology

Consumer Services

Actieve functies van Chihiro Yabe

Bedrijven	Functie	Begin	Einde
Kyoto Prefectural University of Medicine	Corporate Officer/Principal	-	-

Bedrijven	Functie	Begin	Einde
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Oprichter	01-01-2006	-

Internationaal

Zwitserland	2
	2

Operationeel

Founder	1
Corporate Officer/Principal	1

Sectoraal

Health Technology	2
Consumer Services	2

Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Bedrijven in privébezit	1
Calliditas Therapeutics Suisse SA Calliditas Therapeutics Suisse SA Pharmaceuticals: GenericHealth Technology Calliditas Therapeutics Suisse SA engages in the development of NOX therapies. Its platform enables the identification of orally available small-molecules that selectively inhibit specific NOX enzymes, which amplify multiple disease processes such as fibrosis, inflammation, pain processing, cancer development, and neurodegeneration. The company was founded Chihiro Yabe, Robert A. Clark, David Lambeth, and Karl-Heinz Krause in 2006 and is headquartered in Geneva, Switzerland.	Health Technology

Bedrijven in privébezit

Health Technology